Company profile: Legacy Packaging
1.1 - Company Overview
Company description
- Provider of pharmaceutical packaging services including bottle filling (30cc–1500cc), blister packaging (thermoform and coldform), and unit-of-use bottling under its own or client NDC codes with rebate management. Offers Ecoslide compliance packaging (senior-friendly, child-resistant), secondary packaging (cartoning, clamshell/blistershell filling, display assembly, inspection), and inline/offline serialization solutions.
Products and services
- Blister Packaging: custom-engineered blister packaging producing thermoform and coldform blisters, utilizing a variety of tool sets available to meet project-specific pharmaceutical packaging needs
- Bottling Services: industrial-scale bottling for 30cc–1500cc containers, delivering pharmaceutical packaging that caters to various needs across this broad size range for bottles and related specifications
- Serialization Solutions: inline/offline-configurable serialization systems supporting serialization goals with both inline and offline approaches to help bring products to market reliably
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Legacy Packaging
Noramco
HQ: United States
Website
- Description: Provider of design, construction, and management services for bulk active pharmaceutical ingredient plants, including a Wilmington, Delaware facility supporting Ortho-McNeil Pharmaceutical's Tylenol with codeine business; expanded through the acquisition of Tasmanian Alkaloids and the addition of an Athens, Georgia site in 1982.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noramco company profile →
LSL Pharma
HQ: Canada
Website
- Description: Provider of life sciences manufacturing, offering turnkey formulation, development and manufacturing of sterile pharmaceutical products (including ointments) for hospitals, pharmacies and the animal health sector, and natural health products (including solid tablets).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LSL Pharma company profile →
Aldevron
HQ: United States
Website
- Description: Provider of contract manufacturing and scientific services in cell and genetic engineering, specializing in plasmid DNA, protein/enzyme production, and antibody generation. Offers plasmid DNA manufacturing (research to clinical), nanoplasmid design/retrofit, mRNA manufacturing and encapsulation, CRISPR nucleases, RNP complexes, and in vitro transcription and capping enzymes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldevron company profile →
Cambrian Bio
HQ: United States
Website
- Description: Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrian Bio company profile →
Core Diagnostics
HQ: United States
Website
- Description: Provider of full-service esoteric pathology laboratory services; a venture capital-backed laboratory based in Hayward, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Core Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Legacy Packaging
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Legacy Packaging
2.2 - Growth funds investing in similar companies to Legacy Packaging
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Legacy Packaging
4.2 - Public trading comparable groups for Legacy Packaging
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →